市場調査レポート
商品コード
1064730

心停止治療の世界市場:2021年~2027年

Cardiac Arrest Treatment Market 2021-2027

出版日: | 発行: Orion Market Research | ページ情報: 英文 111 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
心停止治療の世界市場:2021年~2027年
出版日: 2022年01月30日
発行: Orion Market Research
ページ情報: 英文 111 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の心停止治療の市場規模は、予測期間中に大幅なCAGRで拡大すると予測されています。座りがちな生活習慣、肥満、糖尿病、喫煙、高コレステロール、高血圧などが、世界の心停止治療市場の成長に大きく寄与しています。

当レポートでは、世界の心停止治療市場について調査し、市場の概要とともに、治療タイプ別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向

第3章 市場の決定要因

  • 促進要因
  • 抑制要因
  • 市場の機会

第4章 市場セグメンテーション

  • 世界の心停止治療市場、治療タイプ別
    • 薬剤
    • 医療機器

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • その他
  • その他の地域

第6章 企業プロファイル

  • Amgen, Inc.
  • Bayer AG
  • Boston Scientific Corp.
  • Bristol-Myers Squibb Company
  • Cardiac Science Corp.(Aurora Capital Group)
  • GE Healthcare
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • Novartis AG
  • Pfizer, Inc.
図表

LIST OF TABLES

  • 1. GLOBAL CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)
  • 2. GLOBAL DRUGS FOR CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL CAPSULES FOR CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 5. NORTH AMERICAN CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 6. NORTH AMERICAN CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)
  • 7. NORTH AMERICAN CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 8. EUROPEAN CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 9. EUROPEAN CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)
  • 10. EUROPEAN CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 11. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 12. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)
  • 13. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 14. REST OF THE WORLD CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)
  • 15. REST OF THE WORLD CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL CARDIAC ARREST TREATMENT MARKET SHARE BY TREATMENT TYPE, 2020 VS 2027 (%)
  • 2. GLOBAL CARDIAC ARREST TREATMENT MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)
  • 3. GLOBAL CARDIAC ARREST TREATMENT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 4. US CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 5. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 6. UK CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 7. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 8. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 9. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 10. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 11. REST OF EUROPE CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 12. INDIA CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 13. CHINA CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 14. JAPAN CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 16. REST OF THE WORLD CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
目次
Product Code: OMR2024216

Global Cardiac Arrest Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Drugs, Medical Devices), Forecast (2021 - 2027)

The global cardiac arrest treatment market is anticipated to grow at a considerable CAGR during the forecast period. Higher inclination towards sedentary lifestyle, obesity, diabetes mellitus, smoking, high cholesterol, and high blood pressure among others are the key contributors to the growth of the global cardiac arrest treatment market.

The global cardiac arrest treatment market is segmented based on treatment type. Based on treatment type, the cardiac arrest treatment market is segmented into drug and medical device. The drugs are further sub-segmented into vasopressors, corticosteroid, anti-arrhythmic drugs, and others. The medical device segment is further sub-segmented into defibrillator, cardiac resynchronization therapy, and others.

Geographically, the global cardiac arrest treatment market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global cardiac arrest treatment market include ZOLL Medical Corp., General Electric Co., Abbott Laboratories, Stryker Corp., Boston Scientific Corp., and Koninklijke Philips N.V. among others.

Market Segmentation

1. Global Cardiac Arrest Treatment Market Research and Analysis by Treatment Type

The Report Covers

  • Comprehensive research methodology of the global cardiac arrest treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global cardiac arrest treatment market.
  • Insights about market determinants that are stimulating the global cardiac arrest treatment market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Market Determinants

  • 3.1. Motivators
  • 3.2. Restraints
  • 3.3. Opportunities

4. Market Segmentation

  • 4.1. Global Cardiac Arrest Treatment Market by Treatment Type
    • 4.1.1. Drugs
      • 4.1.1.1. Vasopressors
      • 4.1.1.2. Corticosteroid
      • 4.1.1.3. Anti-arrhythmic Drugs
      • 4.1.1.4. Others (Beta-blockers and Fibrinolytic drugs)
    • 4.1.2. Medical Devices
      • 4.1.2.1. Defibrillator
      • 4.1.2.2. Cardiac Resynchronization Therapy
      • 4.1.2.3. Others (Ventricular Assist Devices)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Amgen, Inc.
  • 6.2. Bayer AG
  • 6.3. Boston Scientific Corp.
  • 6.4. Bristol-Myers Squibb Company
  • 6.5. Cardiac Science Corp. (Aurora Capital Group)
  • 6.6. GE Healthcare
  • 6.7. Johnson & Johnson
  • 6.8. Koninklijke Philips N.V.
  • 6.9. Novartis AG
  • 6.10. Pfizer, Inc.